Feline diabetes pill gets FDA green lightDecember 9, 2022Bexacat has been approval by the U.S. Food and Drug Administration (FDA) for improved glycemic control in diabetic cats. Developed by Elanco Animal Health, the oral medication, which contains the active ingredient bexagliflozin, marks the first sodium-glucose cotransporter 2 (SGLT2) inhibitor (i.e. not insulin) approved by FDA in any animal species, the agency reports.
SPONSORED CONTENTTips to Facilitate Effective Weight-Loss ConversationsWeight-loss programs that focus on traditional caloric restriction and physical activity may not be appropriate or successful for all families. Incorporating strategies that enhance and support the family-pet relationship can help you create a customized—and successful—plan. +
